NCT00565552 is a NA clinical trial of Silicone gel (Dermatix®) in Cicatrix, Hypertrophic, sponsored by University Hospital Schleswig-Holstein.

Who is sponsoring NCT00565552?

NCT00565552 is sponsored by University Hospital Schleswig-Holstein.

What drugs are being tested in NCT00565552?

Interventions in NCT00565552: Silicone gel (Dermatix®).

What condition does NCT00565552 study?

NCT00565552 studies Cicatrix, Hypertrophic, Keloid.

Is NCT00565552 still recruiting?

NCT00565552 is currently status unknown. Last updated 29 November 2007.

Last reviewed 2007-11-29 · How we verify

NCT00565552

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage for Standardised Total Ear Reconstruction

Status unknown NA Last updated 29 November 2007

What this trial tests

NA trial testing Silicone gel (Dermatix®) in Cicatrix, Hypertrophic in 20 participants. Status unknown.

Timeline

1 January 2007

1 January 2009

Quick facts

Lead sponsor	University Hospital Schleswig-Holstein
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 January 2007
Estimated completion	1 January 2009
Sites	1 location across Germany

Drugs / interventions tested

Silicone gel (Dermatix®) — full drug profile →

Conditions studied

Cicatrix, Hypertrophic — all drugs for Cicatrix, Hypertrophic →
Keloid — all drugs for Keloid →

Sponsor

University Hospital Schleswig-Holstein

Who can join

9 and older, any sex, with Cicatrix, Hypertrophic or Keloid. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Beausang's scar scale, skin elasticity (Cutometer®), skin moisture (Corneometer®), skin color (Chromameter®, Mexameter®), histological evaluation (HE, elastica, actin etc.)
Time frame: 45 minutes

Sponsor's own description

So far the evaluation of scar treatment was based on subjective criteria. The patient groups were divided into treated versus non-treated. In this study we use patients undergoing ear reconstruction with autologous rib cartilage. The thoracic scar of harvesting the rib cartilage is routinely reopened after 3 month during second stage of reconstruction. Therefore we have a ideal model of clinical, physiological and histological scar evaluation in a homologous patient group. All patients randomly treat one half of the scar with a silicone gel (Dermatix). The other half is untreated as an internal control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Current State of Clinical Trials for Keloid Management: An Analysis of Trials Registered on ClinicalTrials.gov.
Park S, Li D, Guo L, Xu X. · · 2026 · PMID 42077711 · DOI 10.7759/cureus.106243

Verify or expand the search:

Other recruiting trials for Cicatrix, Hypertrophic

Currently open trials in the same condition.

NCT06122090 — Treatment of Hypopigmented Scars With Bimatoprost · Phase 2 · recruiting

Other University Hospital Schleswig-Holstein trials

Trials by the same sponsor.

NCT07591376 — A Reminder App to Improve Physical Activity During Radiotherapy for Lung Cancer - a Pre-study in Healthy Volunteers · NA · completed
NCT07286747 — Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) · Phase 2 · recruiting
NCT07380815 — Physical Activity During Radiation Therapy for Lung Cancer · not yet recruiting
NCT07148336 — Identification of Chemotherapy-induced Peripheral Neuropathy · NA · not yet recruiting
NCT07444801 — Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00565552 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Schleswig-Holstein
Last refreshed: 29 November 2007

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00565552.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing